[go: up one dir, main page]

WO2012021733A3 - Systèmes et composés pour atténuer une photodégradation - Google Patents

Systèmes et composés pour atténuer une photodégradation Download PDF

Info

Publication number
WO2012021733A3
WO2012021733A3 PCT/US2011/047468 US2011047468W WO2012021733A3 WO 2012021733 A3 WO2012021733 A3 WO 2012021733A3 US 2011047468 W US2011047468 W US 2011047468W WO 2012021733 A3 WO2012021733 A3 WO 2012021733A3
Authority
WO
WIPO (PCT)
Prior art keywords
systems
photodamage
compounds
reaction
mitigation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/047468
Other languages
English (en)
Other versions
WO2012021733A2 (fr
Inventor
Stephen Yue
Robert Weber
Xiangxu Kong
Andrei Fedorov
John Lyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacific Biosciences of California Inc
Original Assignee
Pacific Biosciences of California Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacific Biosciences of California Inc filed Critical Pacific Biosciences of California Inc
Publication of WO2012021733A2 publication Critical patent/WO2012021733A2/fr
Publication of WO2012021733A3 publication Critical patent/WO2012021733A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/91245—Nucleotidyltransferases (2.7.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

L'invention concerne des compositions, des dispositifs, des systèmes et des procédés pour réduire et/ou prévenir la dégradation photo-induite d'un ou de plusieurs réactifs dans une réaction analytique éclairée par ajout d'un ou de plusieurs composé(s) photoprotecteur(s) au mélange de réaction et pour exécuter la réaction pendant une durée inférieure à une durée seuil de dégradation photo-induite.
PCT/US2011/047468 2010-08-12 2011-08-11 Systèmes et composés pour atténuer une photodégradation Ceased WO2012021733A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40147110P 2010-08-12 2010-08-12
US61/401,471 2010-08-12
US201161466734P 2011-03-23 2011-03-23
US61/466,734 2011-03-23

Publications (2)

Publication Number Publication Date
WO2012021733A2 WO2012021733A2 (fr) 2012-02-16
WO2012021733A3 true WO2012021733A3 (fr) 2012-08-02

Family

ID=45568198

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/047468 Ceased WO2012021733A2 (fr) 2010-08-12 2011-08-11 Systèmes et composés pour atténuer une photodégradation

Country Status (2)

Country Link
US (2) US8834847B2 (fr)
WO (1) WO2012021733A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9127259B2 (en) 2008-03-31 2015-09-08 Pacific Biosciences Of California, Inc. Enzymes resistant to photodamage
US8956816B2 (en) 2012-06-05 2015-02-17 Pacific Biosciences Of California, Inc. Methods and compositions for performing analytical operations
US9637782B2 (en) 2012-09-28 2017-05-02 Pacific Biosciences Of California, Inc. Charged triplet-state quenchers for mitigation of photo-induced damage
US10302972B2 (en) 2015-01-23 2019-05-28 Pacific Biosciences Of California, Inc. Waveguide transmission
CN108350487B (zh) 2015-11-19 2022-05-27 加利福尼亚太平洋生物科学股份有限公司 用于改善信号检测的化合物和系统
JP7075937B2 (ja) * 2016-11-09 2022-05-26 キアゲン サイエンシーズ， エルエルシー Ｓｅｑｕｅｎｃｉｎｇ－Ｂｙ－Ｓｙｎｔｈｅｓｉｓ法におけるイメージング試薬としての光防護性混合物
WO2020006421A1 (fr) 2018-06-29 2020-01-02 Pacific Biosciences Of California, Inc. Procédés et compositions pour l'administration de molécules et de complexes à des sites de réaction
MX2022005327A (es) 2019-11-27 2022-08-04 Illumina Cambridge Ltd Tintes y composiciones que contienen ciclooctatetraeno..
WO2022236241A1 (fr) * 2021-05-03 2022-11-10 Wisconsin Alumni Research Foundation Dérivés de pyridinium obtenus par synthèse hydrothermale pour utilisation en tant qu'anolytes dans des cellules électrochimiques
WO2022241246A1 (fr) * 2021-05-13 2022-11-17 Fluid-Screen, Inc. Techniques pour optimiser la détection de particules capturées par un système microfluidique
WO2023060527A1 (fr) * 2021-10-11 2023-04-20 深圳华大智造科技股份有限公司 Utilisation d'un composé de saponine dans le séquençage d'acide nucléique
US20240201182A1 (en) * 2022-12-15 2024-06-20 Nautilus Subsidiary, Inc. Inhibition of photon phenomena on single molecule arrays

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129642A1 (en) * 1997-04-09 2003-07-10 Biosite Diagnostics, Inc. Novel compositions and methods for inhibiting light-induced inactivation of biological reagents
US20060210440A1 (en) * 1999-11-17 2006-09-21 General Electric Company Opto-acoustic sensor system and associated method
US20070161017A1 (en) * 2005-12-02 2007-07-12 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US20100136592A1 (en) * 2008-11-19 2010-06-03 Pacific Biosciences Of California, Inc. Photo-Induced Damage Mitigating Agents and Preparation and Methods of Use Thereof

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2511428A (en) 1947-05-27 1950-06-13 Nopco Chem Co Antioxidants
US4003919A (en) 1973-11-19 1977-01-18 Hoffmann-La Roche Inc. Antioxidant chroman compounds
US3986980A (en) 1974-04-29 1976-10-19 Hoffmann-La Roche Inc. Synergistic antioxidant composition comprising ascorbic acid and 6-hydroxy-2,5,7,8-tetramethylchroman-2- carboxylic acid
US4302569A (en) 1979-06-21 1981-11-24 Argus Chemical Corporation 2-Chloro-2-alkyl substituted peroxyesters
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
US5821058A (en) 1984-01-16 1998-10-13 California Institute Of Technology Automated DNA sequencing technique
US5476849A (en) 1984-03-19 1995-12-19 The Rockefeller University Methods for glycosylation inhibition using amino-benzoic acids and derivatives
US5514676A (en) 1984-03-19 1996-05-07 The Rockefeller University Amino-benzoic acids and derivatives, and methods of use
DE3425151A1 (de) * 1984-07-07 1986-01-16 Henkel KGaA, 4000 Düsseldorf Haarfaerbemittel
US4689307A (en) 1986-09-02 1987-08-25 Caribbean Microparticles Corporation Fluorescence microscopy sample mounting method and structure
US5242835A (en) 1987-11-03 1993-09-07 Radiometer A/S Method and apparatus for determining the concentration of oxygen
US4962020A (en) 1988-07-12 1990-10-09 President And Fellows Of Harvard College DNA sequencing
US4979824A (en) 1989-05-26 1990-12-25 Board Of Trustees Of The Leland Stanford Junior University High sensitivity fluorescent single particle and single molecule detection apparatus and method
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
WO1991006678A1 (fr) 1989-10-26 1991-05-16 Sri International Sequençage d'adn
EP0428000A1 (fr) 1989-11-03 1991-05-22 Abbott Laboratories Substrats fluorogéniques pour la détection de l'activité prothéolytique d'enzymes
AU668871B2 (en) 1992-06-22 1996-05-23 Auckland Division Cancer Society Of New Zealand Inc Bis-(substituted-phenyl) derivatives with cytotoxic and anticancer activity
CA2155186A1 (fr) 1993-02-01 1994-08-18 Kevin M. Ulmer Methodes et appareil pour le sequencage de l'adn
US6326130B1 (en) 1993-10-07 2001-12-04 Mallinckrodt Baker, Inc. Photoresist strippers containing reducing agents to reduce metal corrosion
WO1996027025A1 (fr) 1995-02-27 1996-09-06 Ely Michael Rabani Dispositif, composes, algorithmes, et procedes de caracterisation et manipulation avec parallelisme moleculaire
US5866331A (en) 1995-10-20 1999-02-02 University Of Massachusetts Single molecule detection by in situ hybridization
ZA973642B (en) 1996-04-26 1997-11-25 Merck & Co Inc DNA vaccine formulations.
DE69735494T2 (de) 1996-09-27 2006-11-23 Takeshi Karita Antioxidierende zusammenstellung zum abfangen von freien radikalen, arzneimittel, welche diese umfasst und verfahren zu deren herstelling
CA2294962C (fr) 1997-07-28 2012-09-18 Medical Biosystems Ltd. Analyse de sequences nucleotidiques
US6068848A (en) 1997-12-17 2000-05-30 Color Access, Inc. Antioxidant mixture comprising tocopherol
EP1105529B2 (fr) 1998-07-30 2013-05-29 Illumina Cambridge Limited Biomolecules en rangees et leur utilisation dans une procedure de sequencage
US6210896B1 (en) 1998-08-13 2001-04-03 Us Genomics Molecular motors
ATE253126T1 (de) 1998-08-25 2003-11-15 Univ Washington Schnelle quantitative analyse von proteinen oder proteinfunktionen in komplexen gemischen
US6232075B1 (en) 1998-12-14 2001-05-15 Li-Cor, Inc. Heterogeneous assay for pyrophosphate detection
AU770803B2 (en) 1998-12-23 2004-03-04 Idea Ag Improved formulation for topical non-invasive application in vivo
US6632655B1 (en) 1999-02-23 2003-10-14 Caliper Technologies Corp. Manipulation of microparticles in microfluidic systems
US7056661B2 (en) 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
WO2001016375A2 (fr) 1999-08-30 2001-03-08 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequençage de molecules d'acide nucleique a grande vitesseen parallele
US6982146B1 (en) 1999-08-30 2006-01-03 The United States Of America As Represented By The Department Of Health And Human Services High speed parallel molecular nucleic acid sequencing
US6917726B2 (en) 2001-09-27 2005-07-12 Cornell Research Foundation, Inc. Zero-mode clad waveguides for performing spectroscopy with confined effective observation volumes
US6869764B2 (en) 2000-06-07 2005-03-22 L--Cor, Inc. Nucleic acid sequencing using charge-switch nucleotides
GB0016473D0 (en) 2000-07-05 2000-08-23 Amersham Pharm Biotech Uk Ltd Sequencing method
GB0016472D0 (en) 2000-07-05 2000-08-23 Amersham Pharm Biotech Uk Ltd Sequencing method and apparatus
US6953659B2 (en) 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of nucleic acids
US6881396B2 (en) 2000-10-24 2005-04-19 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans
US6540923B2 (en) 2000-12-05 2003-04-01 Kurita Water Industries Ltd. Oxygen scavenger
US20020102595A1 (en) 2001-01-29 2002-08-01 Davis Lloyd Mervyn Methods for detection of incorporation of a nucleotide onto a nucleic acid primer
US20030087259A1 (en) 2001-04-18 2003-05-08 Clancy Brian M. Methods and compositions for regulating bone and cartilage formation
DE10129504A1 (de) 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe von Pigmentierungsstörungen
JP2003084002A (ja) 2001-06-27 2003-03-19 Fuji Photo Film Co Ltd 蛍光検出におけるバックグラウンドの低減方法
US7033762B2 (en) 2001-08-29 2006-04-25 Amersham Biosciences Corp Single nucleotide amplification and detection by polymerase
US7244566B2 (en) 2001-08-29 2007-07-17 Ge Healthcare Bio-Sciences Corp. Analyte detection
US7560254B2 (en) 2001-08-29 2009-07-14 Ge Healthcare Bio-Sciences Corp. Allele specific primer extension
US7041812B2 (en) 2001-08-29 2006-05-09 Amersham Biosciences Corp Labeled nucleoside polyphosphates
CN1802409A (zh) 2003-04-08 2006-07-12 西巴特殊化学品控股有限公司 颜料分散体中的光稳定聚合物分散剂
US20050026847A1 (en) 2003-07-28 2005-02-03 Jacobs Robert S. Methods for treating, preventing, or inhibiting injuries, cell membrane stabilization, and calcium mobilization using pseudopterosin compounds
WO2005040119A1 (fr) * 2003-10-01 2005-05-06 Bayer Healthcare Ag Tetrahydro-naphtalene et derives d'uree
US20050141843A1 (en) 2003-12-31 2005-06-30 Invitrogen Corporation Waveguide comprising scattered light detectable particles
DE602005020421D1 (de) 2004-02-19 2010-05-20 Helicos Biosciences Corp Verfahren zur analyse von polynukleotidsequenzen
AU2005240078A1 (en) 2004-04-30 2005-11-17 Allergan, Inc. Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing
DE602006016984D1 (de) 2005-12-12 2010-10-28 Us Gov Health & Human Serv Sonde zum sequenzieren von nukleinsäure und verwendungsverfahren
GB0621361D0 (en) 2006-10-26 2006-12-06 Fermentas Uab Use of DNA polymerases
AU2009212165A1 (en) 2008-02-07 2009-08-13 Pacific Biosciences Of California, Inc. CIS reactive oxygen quenchers integrated into linkers

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129642A1 (en) * 1997-04-09 2003-07-10 Biosite Diagnostics, Inc. Novel compositions and methods for inhibiting light-induced inactivation of biological reagents
US20060210440A1 (en) * 1999-11-17 2006-09-21 General Electric Company Opto-acoustic sensor system and associated method
US20070161017A1 (en) * 2005-12-02 2007-07-12 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US20100136592A1 (en) * 2008-11-19 2010-06-03 Pacific Biosciences Of California, Inc. Photo-Induced Damage Mitigating Agents and Preparation and Methods of Use Thereof

Also Published As

Publication number Publication date
US9732382B2 (en) 2017-08-15
US20120052488A1 (en) 2012-03-01
WO2012021733A2 (fr) 2012-02-16
US20150079603A1 (en) 2015-03-19
US8834847B2 (en) 2014-09-16

Similar Documents

Publication Publication Date Title
WO2012021733A3 (fr) Systèmes et composés pour atténuer une photodégradation
WO2010059880A3 (fr) Agents d'atténuation du dommage photo-induit et préparation et procédés d'utilisation de ces agents
WO2012061290A3 (fr) Compositions pesticides et procédés associés
WO2011090949A3 (fr) Procédés et compositions pour le traitement de réactions chimiques
WO2007064905A3 (fr) Reduction d’une deterioration due a la lumiere dans des reactions analytiques
WO2011141110A3 (fr) Photostabilisateurs
WO2013148843A3 (fr) Compositions d'aérogel précurseur de géopolymère
PH12017501298A1 (en) Pesticidal compositions and processes related thereto
IN2012DN06714A (fr)
WO2011084553A3 (fr) Compositions et utilisations de cis-1,1,1,4,4,4-hexafluorobut-2-ène
WO2014015935A3 (fr) Composés et dispositifs electroniques organiques
HK1217410A1 (zh) Erk抑制劑及其用途
EP2534585A4 (fr) Fractionnement de mots composés
IL221906B (en) pde10 suppressor compounds, preparations containing them and their uses
WO2011133504A3 (fr) Nanozymes, procédés de production de nanozymes, et procédés d'utilisation de nanozymes
WO2012071414A3 (fr) Composés de quinoxaline et leurs utilisations
WO2012115394A3 (fr) Composé, dispositif électronique organique utilisant celui-ci et dispositif électronique associé
MX2015007778A (es) Prediccion de bioactivacion molecular.
WO2011117271A3 (fr) Mélanges fongicides basés sur des azolopyrimidinylamines
WO2011100189A3 (fr) Procédé de prévention ou d'atténuation de la formation d'encrassement biologique
WO2009156724A3 (fr) Nouveaux composés
WO2012054782A3 (fr) Fluoroalkoxylation de composés organiques
WO2012051126A3 (fr) Macrolides antiinflammatoires
WO2013112165A3 (fr) Dispositif d'attache expansible
WO2012051107A8 (fr) Formulations de niacine et procédés ayant un effet secondaire de bouffée congestive réduit

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11817054

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11817054

Country of ref document: EP

Kind code of ref document: A2